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The 50% ethanol extract obtained from Hedera helix leaves was investigated regarding the presence and 
quantity of polyphenols, sterols and in vitro antifungal activity against phytopathogenic fungi. The 
chemical analysis revealed the presence of rutin, quercetin and kaempferol in the non-hydrolysed sample 
and quercetin and kaempferol in the hydrolysed sample and stigmasterol in the ivy leaf extract (non-
hydrolysed sample). The antifungal activity against phytopathogenic fungi (Aspergillus niger, Botrytis 
cinerea, B. tulipae, Fusarium oxysporum f. sp. tulipae, Penicillium gladioli, and Sclerotinia sclerotiorum) 
was assessed using an agar dilution assay. The results are expressed as the minimum inhibitory concentra-
tion (MIC = 10–14%) and were compared to a synthetic antifungal drug – fluconazole (MIC = 8–30%). 
This report presents the first screening of the antifungal activity of the ivy leaf extract on these plant 
pathogenic fungi species, aiming to use the ivy leaf extract for controlling different diseases of vegetables 
and ornamental plants, in addition to human disorders.
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INTRODUCTION
Hedera helix (ivy) is an evergreen woody liana (Araliaceae family) native to most of 
Europe and Western Asia. The leaves are alternate, evergreen with an accentuated 
polymorphism; thus, the juvenile leaves are palmate with 3–5 lobes, while the adult 
ones are cordate, rhomboid to ovate-lanceolate. The flowers produced from summer 
until late autumn are small, greenish-yellow and come in umbels of 3–5 cm in diam-
eter. The fruits are small black berries that ripen in winter. It is a popular ornamental 
plant in many countries [13].
In addition to its ornamental value, ivy is used as a medicinal plant. The ivy leaf 
has been used since ancient times (Dioscorides and Hippocrates), but the phytothera-
peutical books of the 16th century would describe very different indications. 
Steinmetz, in 1961, presumed that although the plant is decidedly poisonous (in large 
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doses death can occur by respiratory paralysis), the leaves and berries administered 
in safe doses have some good uses in therapy [37].
The aim of the present research was to investigate the antifungal properties of the 
ivy leaf extract against plant pathogenic fungi and to identify and quantify the phe-
nolic compounds and sterols from the leaf extract that are believed to be responsible 
for the antifungal activity.
MATERIALS AND METHODS
Plant material
Hedera helix was collected from the Alexandru Borza Botanical Garden of Cluj-
Napoca (46°45′36″N; 23°35′13″E), and a voucher specimen (CL 664210) is depos-
ited at the Herbarium of Babes-Bolyai University, Cluj-Napoca, Romania.
Plant extract preparation
The plant extract was prepared by a cold repercolation method at room temperature 
for 3 days [30] by using small fragments (0.5–1 cm) of ivy leaves, which were 
extracted with 50% ethanol (Merck, Bucuresti, Romania) in the Mycology Laboratory 
of Babes-Bolyai University, Cluj-Napoca, Romania. The Drug Extract Ratio (DER) 
was 1:1.
Preparation of fungal colonies
The plant pathogenic fungi chosen for the experiment cause important losses to veg-
etable and ornamental crops and have never been used to test the antifungal properties 
of ivy leaf extract. For this purpose, Aspergillus niger was isolated from onion bulbs, 
Botrytis cinerea from rose flowers, B. tulipae and Fusarium oxysporum f. sp. tulipae 
from tulip flowers and bulbs, respectively, Penicillium gladioli from gladiolus corms, 
and Sclerotinia sclerotiorum from carrot roots. All the fungal species were identified 
in the Mycology Laboratory (Babes-Bolyai University, Cluj-Napoca, Romania), by 
Dr. M. Parvu. The colonies were obtained in Petri dishes on Czapek-agar medium 
(BD Difco, Budapest, Hungary) by inoculation in the central point with a spore sus-
pension (1×105 conidia × mL–1) and an incubation at 22 °C for 5 days.
Determination of antifungal activity
The antifungal activity of the Hedera helix leaf extract, expressed as MIC, was 
assessed by the agar dilution assay and was compared to the antimycotic drug flu-
conazole (2 mg × mL–1, Krka, Novo Mesto, Slovenia) and a control (nutritive medium 
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and ethanol). The results were interpreted by calculating the percentage of mycelial 
growth inhibition (P) at each concentration, by using the formula P = (C – T) × 100/C, 
where C is the diameter of the control colony and T is the diameter of the treated 
colony [21].
Analysis of polyphenols from the ivy leaf extract
Apparatus and chromatographic conditions
The experiment was carried out using an Agilent 1100 HPLC Series system equipped 
with an autosampler G1311A. For the separation, a reversed-phase Zorbax SB-C18 
analytical column (100 × 3.0 mm i.d., 3.5 µm particle) was used. The column was 
operated at 48 °C in a G1316A oven. For the gradient elution, a degasser G1322A and 
quaternary gradient pump G1311A were employed. The detection of all of the com-
pounds was performed at 330 and 370 nm using G1316A diode array detector system, 
and the chromatographic data were processed with the Chemstation software 
(Agilent, USA). The mobile phase was prepared from methanol and acetic acid 0.1% 
(V × V–1). The elution began with a linear gradient (started at 5 to 42% methanol) 
for the first 35 min, followed by an isocratic elution with 42% methanol for the next 
3 min.
The flow rate was 1 mL × min–1, and the injection volume was 5 µL. All of the 
solvents were filtered through 0.5 µm filters (Sartorius) and we degassed in an 
ultrasonic bath. For the liquid chromatography (LC) electrospray ionization (ESI) 
mass spectrometry (MS) analysis, an Agilent Ion Trap 1100 SL instrument was 
used. The MS was equipped with a Turbo-Ionspray (electrospray ionization) inter-
face in negative ion mode. The ESI settings were as follows: negative ionization; 
ion source temperature: 350 °C; gas: nitrogen at 12 L × min–1; and nebulizer: 70 psi 
[11, 22, 24, 35].
Chemicals
Standards: chlorogenic acid, p-coumaric acid, caffeic acid, rutin, apigenin, quercitrin, 
isoquercitrin, hyperoside, kaempferol, quercetin, myricetol and fisetin were pur-
chased from Sigma (Germany); ferulic acid, sinapic acid, gentisic acid, patuletin and 
luteolin from Roth (Germany); and cichoric acid and caftaric acid from Dalton 
(USA). Methanol of HPLC analytical-grade and hydrochloric acid of analytical-grade 
were purchased from Merck (Germany). Methanolic stock solutions (1 mg × mL–1) of 
the above standards were prepared, stored at 4 °C, and were protected from daylight. 
They were appropriately diluted with double-distilled water before being used as 
working solutions.
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Identification and quantitative determination of the polyphenols
A high-performance liquid chromatographic (HPLC) method was developed for the 
determination of phenolic compounds from ivy extract [35]. The simultaneous analy-
sis of different classes of polyphenols was performed by a single column pass, and 
the separation of all of the examined compounds was carried out in 35 min. To obtain 
more accurate data on the flavonoid glycosides and aglycones concentrations and to 
estimate the nature of the hydrolysed compounds, each sample was analysed once 
before and after the acid hydrolysis. The concentrations of the identified polyphe-
nolic compounds were determined in all of the analysed samples before and after the 
acid hydrolysis. Two millilitres of the extract was treated with 2 mL of 2 M hydro-
chloric acid and 0.2 mL of the ascorbic acid solution 100 mg × mL–1, and the mixtures 
were heated at 80 °C in a water bath for 30 min, ultrasonicated for 15 min and heated 
for another 30 min at 80 °C. During the heating, 1 mL methanol was added to the 
extraction mixture every 10 min in order to ensure the permanent presence of metha-
nol. The mixtures were centrifuged at 4000 rpm, and the solutions were diluted with 
distilled water in a 10 mL volumetric flask and were filtered through a 0.45 mm filter 
before injection.
Identification and quantitative determination of sterols
The LC-MS technique was also used to analyse the sterols from the ivy leaf extract. 
Thus, a Zorbax SB-C18 reversed-phase analytical column (100 × 3.0 mm i.d., 3.5 μm 
particle) operated at 40 °C was used. The separation was achieved using a mobile 
phase consisting of 10:90 (V/V) methanol and acetonitrile with a flow rate of 1 mL/
min and an injection volume of 5 μL. Mass spectrometry analysis was performed on 
an Agilent Ion Trap 1100 VL mass spectrometer with atmospheric pressure chemical 
ionization (APCI) interface. The instrument was operated in a positive ion mode. The 
gas temperature (nitrogen) was 325 °C at a flow rate of 7 L/min, nebulizer pressure 
60 psi and capillary voltage –4000 V. Three standards were used for the quantitative 
analysis, namely β-sitosterol, stigmasterol, and cholesterol.
Statistical analysis
The statistical analyses of the experimental data were performed in the R environ-
ment (version 2.14.1) using a one-way ANOVA and the post hoc Tukey HSD test for 
the significance of differences between treatments. P values ≤ 0.05 were considered 
to be statistically significant. The correlation analysis was performed by the Pearson 
test.
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RESULTS
The analysis of polyphenols from the Hedera helix leaf extract revealed the presence 
of rutin, quercetin and kaempferol in the non-hydrolysed sample (Fig. 1) and querce-
tin and kaempferol in the hydrolysed sample (Fig. 2). The quantification of the poly-
phenols in the ivy leaf extract displayed a quantity of 120.655 ± 6.032 µg × mL–1 rutin, 
1.550 ± 0.069 µg × mL–1 quercetin, and 1.278 ± 0.063 µg × mL–1 kaempferol in the 
non-hydrolysed sample, and 24.068 ± 1.203 µg × mL–1 quercetin, 7.513 ± 0.338 
µg × mL–1 kaempferol in the hydrolysed sample, whereas the analysed sample of the 
ivy leaf extract contained 0.373 ± 0.018 ng × mL–1 stigmasterol.
Taking into consideration some of the most frequent diseases of vegetables and 
ornamentals, 6 phytopathogenic fungi (Aspergillus niger, Botrytis cinerea, B. tulipae, 
Fusarium oxysporum f. sp. tulipae, Penicillium gladioli, and Sclerotinia sclerotio-
rum) were selected for testing the antifungal properties of the Hedera helix leaf 
extract. The extract inhibited the germination and growth of the plant pathogenic 
fungi in a concentration-dependent manner. The minimum inhibitory concentration 
(MIC) varied between 10% and 14% (P ≤ 0.05) for the leaf extract compared to 8% 
and 30% (P ≤ 0.05) for fluconazole (Table 1). These results are comparable with those 
obtained in our previous study for the ivy flower extract (MIC = 8–12%) and fruit 
Fig. 1. Chromatogram of the polyphenols from the non-hydrolysed sample of the Hedera helix leaf 
extract. The peaks are marked: “1” rutin; “2” quercetin; “3” kaempferol
Fig. 2. Chromatogram of the polyphenols from the hydrolysed sample of the Hedera helix leaf extract. 
The peaks are marked: “1” quercetin; “2” kaempferol
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Table 1
In vitro effect of the Hedera helix leaf extract
Phyto - 
pathogenic  
fungus
Hedera helix 
leaf extract 
(1:1)  
concentration 
(%)
Colony’s  
diametera
(mm)
Pa
(%)
Fluconazole
(2 mg × mL–1)  
concentration
Colony’s 
diameterb
(mm)
P b
(%)
(%) (mg × mL–1)
Aspergillus 
niger
C 22 0 C 22 0
6 18 18.18 ± 0.81 10 0.2 11 54.13 ± 0.50
8 15 31.81 ± 0.50 20 0.4 7 68.18 ± 0.50
10 8 63.63 ± 0.57 25 0.5 3 86.36 ± 0.57
12 2 90.90 ± 0.57 30 0.6 0 100
14 0 100
Botrytis  
cinerea
C 65 0 C 65 0
3 44 32.30 ± 0.50 2 0.04 40 38.46 ± 0.50
6 11 83.07 ± 0.81 6 0.12 20 69.23 ± 0.95
8 4 93.84 ± 0.95 10 0.20 3 95.38 ± 0.50
10 0 100 12 0.24 0 100
Botrytis  
tulipae
C 62 0 C 62 0
3 41 33.87 ± 0.50 2 0.04 50 19.35 ± 0.50
6 10 83.87 ± 0.50 6 0.12 24 61.29 ± 0.81
8 3 95.16 ± 0.57 10 0.20 3 95.16 ± 0.50
10 0 100 12 0.24 0 100
Fusarium  
oxysporum  
f. sp. tulipae
C 32 0 C 32 0
3 29 9.37 ± 0.57 2 0.04 20 37.5 ± 0.50
6 17 46.87 ± 0.50 6 0.12 8 75 ± 0.50
8 12 62.5 ± 0.50 8 0.16 2 93.75 ± 0.57
10 4 87.5 ± 0.81 10 0.20 0 100
12 0 100
Penicillium 
gladioli
C 15 0 C 15 0
3 11 26.66 ± 0.50 10 0.2 11 26.66 ± 0.50
6 7 53.33 ± 0.81 16 0.32 9 40 ± 0.50
8 3 80 ± 0.57 20 0.4 6 60 ± 0.50
10 0 100 25 0.5 3 80 ± 0.50
30 0.6 0 100
Sclerotinia  
sclerotiorum
C 64 0 C 64 0
3 31 51.56 ± 0.50 2 0.04 30 53.12 ± 0.50
6 15 76.56 ± 0.57 4 0.08 15 76.56 ± 0.50
8 3 95.31 ± 0.81 6 0.12 4 93.75 ± 0.57
10 0 100 8 0.16 0 100
Legend: athe effect of the Hedera helix leaf extract; bthe effect of fluconazole; P = mycelial growth inhibition; 
C = control (50% aq. EtOH); results are the mean ± SD of 4 replicates.
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Fig. 3. The antifungal activity of the Hedera helix leaf extract on the germination and growth of the 
Botrytis cinerea fungus: 1 – control colony (left) and colony treated with 3% ivy leaf extract (right), 
5 days after inoculation; 2 – colony treated with 6% ivy leaf extract, 5 days after inoculation; 3 – colony 
treated with 8% ivy leaf extract, 5 days after inoculation; 4 – colony treated with 10% ivy leaf extract, 5 
days after inoculation (total inhibition)
Fig. 4. The antifungal activity of the Hedera helix leaf extract on the germination and growth of the 
Sclerotinia sclerotiorum fungus: 1 – control colony, 14 days from inoculation (left) and colony treated 
with 2% ivy leaf extract, 5 days after inoculation (right); 2 – Colony treated with 6% ivy leaf extract (left) 
and colony treated with 10% ivy leaf extract (right), 5 days after inoculation (total inhibition)
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extract (MIC = 10–14%) [23]. These findings suggest that ivy flowers contain princi-
ples with higher antifungal activities and might be more efficient in treating plant 
mycoses.
Ivy leaf extract inhibited, in a similar manner, the fungi causing grey mould 
(Botrytis cinerea – Fig. 3, B. tulipae), blue mould (Penicillium gladioli) and white rot 
(Sclerotinia sclerotiorum – Fig. 4) of plants. The MIC for all of these fungi was 10%. 
Less of an inhibitory effect was recorded in the case of Fusarium oxysporum f. sp. 
tulipae, with a MIC of 12%. The most resistant of all of the selected fungi was 
Aspergillus niger, with a MIC of 14%. At any rate, the obtained results are better than 
those for fluconazole (Table 1), which makes the ivy leaf extract a promising biocon-
trol agent for plant pathogenic fungi.
DISCUSSION
The antifungal activity of plant extracts is due to chemical constituents, such as alka-
loids, polyphenols, saponins, sterols and essential oils [31]. Therefore, it is important 
to identify and quantify such bioactive compounds using adequate methods [3].
The phytochemical screening of Hedera helix indicated the presence of different 
classes of secondary metabolites, such as alkaloids, terpenoids, saponins and tannins. 
These compounds vary in type in different parts of the plant and are dependent on the 
type of the solvent used for the extraction. The chloroform and methanolic extracts 
revealed the presence of alkaloids, while terpenoids, saponins, and tannins were pre-
sent in the n-hexane, chloroform, ethyl acetate and methanol extracts, respectively 
[33]. In the methylene chloride extract, from the leaves of Hedera helix, the following 
active components were found: β-amyrin; stigmasterol and hexadecanoic acid [20].
Using a new solid-liquid extraction technique highlighted the presence of active 
ingredients in the aqueous leaf extract of Hedera helix. Thus, flavonoids, proteins, 
amino acids and small amounts of triterpene saponins were recorded. In the extract, 
the flavonoids rutin, quercetin, kaempferol, and apigenin were identified, and the 
amino acids asparagine, glycine, isoleucine, leucine, phenylalanine, proline, tyrosine, 
and valine were identified by means of chromatographic methods [10].
Numerous studies have investigated the bioactive compounds of Hedera helix. 
Such studies used different methods to identify the compounds. Thus, triterpene 
saponins, such as hederasaponins E(1), F(2), H(7) and I(8) and cauloside F, were 
isolated from the leaves of Hedera helix and were characterised by chemical and 
spectroscopic methods [9]. The saponins hederacoside C and α-hederin, from differ-
ent ivy leaf extracts, were detected using reversed-phase high-HPLC [6].
A thorough investigation of the phenolic constituents from the dry extract of 
Hedera helix revealed the presence of rutin, kaempferol 3-O-rutinoside, quercetin 
3-O-glucoside, kaempferol 3-O-glucoside, quercetin, kaempferol, chlorogenic acid, 
neochlorogenic acid, 4,5- and 3,5-O-dicaffeoyl-quinic acids, as well as rosmarinic, 
caffeic, and protocatechuic acids. These compounds were isolated and identified by 
spectroscopic methods [32].
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Furthermore, data from the literature mention the presence of emetine alkaloid in 
the ivy plant. Emetine is a natural product alkaloid found in several plant species. Its 
structure was elucidated, and its biological properties were studied. Thus, the antivi-
ral, anticancer, antiparasitic and contraceptive activities were assigned. The major 
problem discouraging the medicinal use of this alkaloid is represented by cardiotoxic-
ity and cytotoxicity, but these are dose-dependent [1]. Emetine alkaloid was separated 
for the first time from the alcoholic extract of the four varieties of Hedera helix grow-
ing in Egypt. The presence of the alkaloid was investigated by applying IR, UV, NMR 
and MS analyses [17]. Another innovative, sensitive and accurate method for the 
isolation and quantification of emetine alkaloid is the RP-HPLC [15].
Even if most of the studies elucidate the chemical composition of plant extracts, 
we believe that it is equally important to quantify the bioactive substances, because 
they might be very different depending on the plant organ, the solvent, and the 
method used for extraction. 
The goal after identifying and isolating biologically active compounds from plants 
is to study them as possible curing agents. These kinds of studies are related espe-
cially to the therapeutic properties of the bioactive compounds, which are mainly 
used to treat human disorders. Such studies showed the anti-inflammatory effect of 
ivy, specifically the saponins extracted from the leaves of Hedera helix [7] and the 
anti-inflammatory and antiarthritic effects of the ethanolic extract of Hedera helix, 
which were found to be comparable to that of diclofenac [26]. Additionally, the 
methanolic extract of Hedera helix leaves and the saponins (hederacolchiside-E and 
-F) have dose-dependent analgesic and anti-inflammatory activities [12, 19]. 
A number of studies regarding ivy properties have demonstrated its benefits in 
respiratory diseases. Such studies confirmed that ivy leaf extract, in the form of syrup 
and in cough drops, is an effective and safe treatment of cough in children [28], in 
acute bronchitis therapy [4], and for acute upper respiratory tract infections, in gen-
eral [16]. The traditional use of ivy for medicinal purposes is confirmed by its secre-
tolytic, expectorant, and bronchospasmolytic effects, mainly due to the triterpene 
saponins, which are the main ingredients and are pharmacologically the most impor-
tant substances from the ivy leaf extracts [29]. Moreoever, the Hedera helix extract 
was reported to have antitumour [25] and antimutagenic [34] effects, antioxidant 
properties due to the saponins (α-hederin and hederasaponin-C) [14], hypoglycemic 
activity [36], antileishmanial [18] and antihelmintic [8] properties.
Studies regarding the antimicrobial properties of the Hedera helix extracts are 
incomparably fewer. Such studies mention that the aqueous extract of Hedera helix 
has antibacterial, antimycobacterial and antifungal activities [5]. The ethyl acetate 
and methanol extracts were active against two strains of Gram-negative bacteria 
(Escherichia coli, Klebsiella pneumoniae) and three strains of Gram-positive bacteria 
(Staphylococcus aureus, S. epidermidis, Bacillus subtilis) at concentration of 22 
mg × mL–1 [33]. 
In addition to its therapeutic properties for human disorders, there are a few studies 
related to the antibacterial and antifungal activity of the ivy extract against plant 
pathogenic agents. Interesting results were obtained when testing the antibacterial 
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effect of the Hedera helix extract against Erwinia amylovora. The ivy extract caused 
a pronounced increase in peroxidase and chitinase activity and induced the activation 
of defence genes, leading to the accumulation of structural and biochemical activities 
at strategic sites, which can be associated with induction of resistance against fire-
blight [2]. More specifically, the ethanolic extract of Hedera helix exhibited a high 
degree of antifungal activity against late blight (Phytophthora infestans) of tomato 
and downy mildew (Pseudoperonospora cubensis) of cucumber [27].
Previous studies attest the antifungal properties of ivy extract against plant patho-
genic fungi, while our results contribute the data in the literature on this topic with 
useful information regarding the possibility of being able to control plant pathogenic 
fungi that cause important and frequent diseases to vegetables and ornamental plants. 
Further studies should consider the assessment of the specific bioactive compound 
with the highest antifungal activity.
CONCLUSIONS
The ivy leaf ethanolic extract exhibited antifungal activity against the tested phy-
topathogenic fungi (Aspergillus niger, Botrytis cinerea, B. tulipae, Fusarium oxyspo-
rum f. sp. tulipae, Penicillium gladioli and Sclerotinia sclerotiorum) in a dose-
dependent manner with an MIC of 10% to 14%. The results were comparable to those 
obtained for a synthetic drug (fluconazole), which makes ivy leaf extract a cost-
effective and a potent herbal control agent for the treatment of plant diseases, such as 
grey mould, plant wilt and white rot. We believe that the antifungal activity is highly 
due to the polyphenols (rutin, quercetin, kaempferol) and the sterol (stigmasterol) that 
were detected in considerable amounts in the ivy leaf extract. Also, the role of the 
saponins with proven antifungal activity cannot be overlooked.
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